BSACI guidelines for the management of chronic urticaria and angio-oedema

Clinical and Experimental Allergy

Volumn 37, Issue 5, 2007, Pages 631-650

  Powell, R J ^a   Du Toit, G L ^b   Siddique, N ^c   Leech, S C ^b   Dixon, T A ^d   Clark, A T ^e   Mirakian, R ^e   Walker, S M ^f   Huber, P A J ^g   Nasser, S M ^e,h  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST MARY S HOSPITAL   (United Kingdom)

^d ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

^f Addenbrooke's Hospital ^*  (United Kingdom)

^g British Society for Allergy and Clinical Immunology   (United Kingdom)

^h Clinic 2A   (United Kingdom)

Author keywords

Allergy; Angio oedema; Antihistamine; Autoantibody; Autoimmune; Breastfeeding; BSACI; Child; Guideline; Hypo thyroidism; IgE; Paraprotein; Pregnancy; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; ACRIVASTINE; ADRENALIN; ALLOPURINOL; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CETIRIZINE; CHLORPHENIRAMINE; CITALOPRAM; CORTICOSTEROID; CYCLOSPORIN; DESLORATADINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTROGEN; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYDROXYZINE; IMMUNOGLOBULIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; LORATADINE; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PREDNISOLONE; PROMETHAZINE; TRANEXAMIC ACID; UNINDEXED DRUG;

ADD ON THERAPY; ANAMNESIS; ANGIONEUROTIC EDEMA; ATTENTION; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; BLOOD CELL COUNT; BREAST FEEDING; CELIAC DISEASE; CHEMOPROPHYLAXIS; CHILDHOOD DISEASE; CHRONIC URTICARIA; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CONNECTIVE TISSUE DISEASE; CONSULTATION; CONTACT URTICARIA; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DROWSINESS; DRUG CONTRAINDICATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG EXCRETION; DRUG MECHANISM; DRUG MEGADOSE; DRUG USE; DRUG WITHDRAWAL; ENDOSCOPY; ERYTHROCYTE SEDIMENTATION RATE; EVIDENCE BASED PRACTICE; HUMAN; LIVER FUNCTION TEST; LOW DRUG DOSE; MEDICAL EXPERT; MEMORY; OPTIMAL DRUG DOSE; PARASITOLOGY; PATHOGENESIS; PATIENT CARE; PATIENT EDUCATION; PEDIATRICIAN; PHYSICAL EXAMINATION; PHYSICIAN; PRACTICE GUIDELINE; PREGNANT WOMAN; PRICK TEST; PRIORITY JOURNAL; PROGNOSIS; PROVOCATION TEST; PSYCHOMOTOR RETARDATION; REVIEW; SEDATION; SERUM; SIDE EFFECT; SKIN BIOPSY; SKIN TEST; SPONTANEOUS ABORTION; SYMPTOMATOLOGY; THYROID FUNCTION; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; URINALYSIS; URTICARIA; VASCULITIS; WEB BROWSER;

ADULT; ALGORITHMS; ANGIONEUROTIC EDEMA; BREAST FEEDING; CHILD; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PROGNOSIS; URTICARIA;

EID: 34247351279     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02678.x     Document Type: Review

References (121)

1. Greaves MW. Chronic idiopathic urticaria. Curr Opin Allergy Clin Immunol 2003 3: 363 8.
2. Gaig P, Olona M, Munoz LD et al. Epidemiology of urticaria in Spain. J Invest Allergol Clin Immunol 2004 14: 214 20.
3. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997 136: 197 201.
4. Baiardini I, Giardini A, Pasquali M et al. Quality of life and patients' satisfaction in chronic urticaria and respiratory allergy. Allergy 2003 58: 621 3.
5. Kozel MM, Sabroe RA. Chronic urticaria: aetiology, management and current and future treatment options. Drugs 2004 64: 2515 36.
6. Sabroe RA, Fiebiger E, Francis DM et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002 110: 492 9.
7. Kaplan AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002 346: 175 9.
8. Vazquez NF, Meida Arvizu VM, Sanchez Nuncio HR, Villanueva Carreto ML, Guidos FogelbachGA. Prevalence and potential triggering factors of chronic urticaria and angioedema in an urban area of northeastern Mexico. Rev Alerg Mex 2004 51: 181 8.
9. Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999 40: 443 50.
10. Oliver MG, Specian RD, Perry MA, Granger DN. Morphologic assessment of leukocyte-endothelial cell interactions in mesenteric venules subjected to ischemia and reperfusion. Inflammation 1991 15: 331 46.
11. Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002 186: 8 18.
12. Du Toit G, Prescott R, Lawrence P et al. Autoantibodies to the high-affinity IgE receptor in children with chronic urticaria. Ann Allergy Asthma Immunol 2006 96: 341 4.
13. Brunetti L, Francavilla R, Miniello VL et al. High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 2004 114: 922 7.
14. Asero R, Tedeschi A, Lorini M, Salimbeni R, Zanoletti T, Miadonna A. Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 2001 31: 1105 10.
15. Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol 1999 104: 169 72.
16. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989 84: 66 71.
17. Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983 119: 636 40.
18. Rumbyrt JS, Katz JL, Schocket AL. Resolution of chronic urticaria in patients with thyroid autoimmunity. J Allergy Clin Immunol 1995 96: 901 5.
19. Kikuchi Y, Fann T, Kaplan AP. Antithyroid antibodies in chronic urticaria and angioedema. J Allergy Clin Immunol 2003 112: 218.
20. Reichel M, Mauro TM. Urticaria and hepatitis C. Lancet 1990 336: 822 3.
21. Kanazawa K, Yaoita H, Tsuda F, Okamoto H. Hepatitis C virus infection in patients with urticaria. J Am Acad Dermatol 1996 35: 195 8.
22. Siddique N, Pereira BN, Hasan AS. Hepatitis C and urticaria: cause and effect? Allergy 2004 59: 668.
23. Vaida GA, Goldman MA, Bloch KJ. Testing for hepatitis B virus in patients with chronic urticaria and angioedema. J Allergy Clin Immunol 1983 72: 193 8.
24. Black AK, Lawlor F, Greaves MW. Consensus meeting on the definition of physical urticarias and urticarial vasculitis. Clin Exp Dermatol 1996 21: 424 6.
25. Kushimoto H, Aoki T. Masked type I wheat allergy. Relation to exercise-induced anaphylaxis. Arch Dermatol 1985 121: 355 60.
26. Papadopoulou N, Kalogeromitros D, Staurianeas NG, Tiblalexi D, Theoharides TC. Corticotropin-releasing hormone receptor-1 and histidine decarboxylase expression in chronic urticaria. J Invest Dermatol 2005 125: 952 5.
27. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004 114: 465 74.
28. Agostoni A, Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 2001 24: 599 606.
29. Lee A. Adverse drug reactions, 2nd Edn. London Pharmaceutical Press, London and Chicago, 2006.
30. Kaplan AP. C1 inhibitor deficiency: hereditary and acquired forms. J Invest Allergol Clin Immunol 2001 11: 211 9.
31. Vleeming W, van Amsterdam JG, Stricker BH, de Wildt DJ. ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 1998 18: 171 88.
32. Kostis JB, Kim HJ, Rusnak J et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 2005 165: 1637 42.
33. Guo X, Dick L. Late onset angiotensin-converting enzyme induced angioedema: case report and review of the literature. J Okla State Med Assoc 1999 92: 71 73.
34. Cicardi M, Zingale LC, Bergamaschini L, Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 2004 164: 910 3.
35. Dean DE, Schultz DL, Powers RH. Asphyxia due to angiotensin converting enzyme (ACE) inhibitor mediated angioedema of the tongue during the treatment of hypertensive heart disease. J Forensic Sci 2001 46: 1239 43.
36. Pavletic AJ. Late angio-oedema in patients taking angiotensin-converting- enzyme inhibitors. Lancet 2002 360: 493 4.
37. Warrier MR, Copilevitz CA, Dykewicz MS, Slavin RG. Fresh frozen plasma in the treatment of resistant angiotensin-converting enzyme inhibitor angioedema. Ann Allergy Asthma Immunol 2004 92: 573 5.
38. Karim MY, Masood A. Fresh-frozen plasma as a treatment for life-threatening ACE-inhibitor angioedema. J Allergy Clin Immunol 2002 109: 370 1.
39. Gompels MM, Lock RJ, Abinun M et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005 139: 379 94.
40. Humphreys F, Hunter JA. The characteristics of urticaria in 390 patients. Br J Dermatol 1998 138: 635 8.
41. Champion RH. Urticaria: then and now. Br J Dermatol 1988 119: 427 36.
42. Toubi E, Kessel A, Avshovich N et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004 59: 869 73.
43. Kozel MM, Mekkes JR, Bossuyt PM, Bos JD. The effectiveness of a history-based diagnostic approach in chronic urticaria and angioedema. Arch Dermatol 1998 134: 1575 80.
44. Ewan PW. Clinical study of peanut and nut allergy in 62 consecutive patients: new features and associations. BMJ 1996 312: 1074 8.
45. Chong SU, Worm M, Zuberbier T. Role of adverse reactions to food in urticaria and exercise-induced anaphylaxis. Int Arch Allergy Immunol 2002 129: 19 26.
46. Dohi M, Suko M, Sugiyama H et al. Food-dependent, exercise-induced anaphylaxis: a study on 11 Japanese cases. J Allergy Clin Immunol 1991 87: 34 40.
47. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza BA, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999 140: 446 52.
48. Zuberbier T, Munzberger C, Haustein U et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology 1996 193: 324 7.
49. Zuberbier T, Ifflander J, Semmler C, Henz BM. Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol 1996 76: 295 7.
50. Pollack CV Jr., Romano TJ. Outpatient management of acute urticaria: the role of prednisone. Ann Emerg Med 1995 26: 547 51.
51. Leurs R, Church MK, Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects. Clin Exp Allergy 2002 32: 489 98.
52. Simons FE. Advances in H1-antihistamines. N Engl J Med 2004 351: 2203 17.
53. Monroe EW, Fox RW, Green AW et al. Efficacy and safety of loratadine (10 mg once daily) in the management of idiopathic chronic urticaria. J Am Acad Dermatol 1988 19: 138 9.
54. Ring J, Hein R, Gauger A, Bronsky E, Miller B. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Int J Dermatol 2001 40: 72 6.
55. Di Lorenzo G, Pacor ML, Mansueto P et al. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. J Allergy Clin Immunol 2004 114: 619 25.
56. Finn AF Jr., Kaplan AP, Fretwell R, Qu R, Long J. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1999 104: 1071 8.
57. Juhlin L, Arendt C. Treatment of chronic urticaria with cetirizine dihydrochloride a non-sedating antihistamine. Br J Dermatol 1988 119: 67 71.
58. Goh CL, Wong WK, Lim J. Cetirizine vs placebo in chronic idiopathic urticaria - a double blind randomised cross-over study. Ann Acad Med Singapore 1991 20: 328 30.
59. Schroter S, Damveld B, Marsch WC. Urticarial intolerance reaction to cetirizine. Clin Exp Dermatol 2002 27: 185 7.
60. Tella R, Gaig P, Bartra J, Garcia-Ortega P. Urticaria to cetirizine. J Invest Allergol Clin Immunol 2002 12: 136 7.
61. Kapp A, Pichler WJ. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. Int J Dermatol 2005 54: 469 74.
62. van Joost T, Blog FB, Westerhof W et al. A comparison of acrivastine versus terfenadine and placebo in the treatment of chronic idiopathic urticaria. J Int Med Res 1989 17 (Suppl. 2): 14B 7B.
63. Hindmarch I, Johnson S, Meadows R, Kirkpatrick T, Shamsi Z. The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare. Curr Med Res Opin 2001 17: 241 55.
64. Handa S, Dogra S, Kumar B. Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. J Dermatolog Treat 2004 15: 55 7.
65. Curran MP, Scott LJ, Perry CM. Cetirizine: a review of its use in allergic disorders. Drugs 2004 64: 523 61.
66. Verster JC, Volkerts ER, van Oosterwijck AW et al. Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. J Allergy Clin Immunol 2003 111: 623 7.
67. Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004 113: 134 40.
68. Pacor ML, Di Lorenzo G, Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 2001 31: 1607 14.
69. Perez C, Sanchez-Borges M, Capriles E. Pretreatment with montelukast blocks NSAID-induced urticaria and angioedema. J Allergy Clin Immunol 2001 108: 1060 1.
70. Reimers A, Pichler C, Helbling A, Pichler WJ, Yawalkar N. Zafirlukast has no beneficial effects in the treatment of chronic urticaria. Clin Exp Allergy 2002 32: 1763 8.
71. Sanada S, Tanaka T, Kameyoshi Y, Hide M. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria. Arch Dermatol Res 2005 297: 134 8.
72. White M, Rothrock S, Meeves S, Liao Y, Georges G. Comparative effects of fexofenadine and montelukast on allergen-induced wheal and flare. Allergy Asthma Proc 2005 26: 221 8.
73. Nettis E, Colanardi MC, Paradiso MT, Ferrannini A. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy 2004 34: 1401 7.
74. Nettis E, Pannofino A, Cavallo E, Ferrannini A, Tursi A. Efficacy of montelukast, in combination with loratadine, in the treatment of delayed pressure urticaria. J Allergy Clin Immunol 2003 112: 212 3.
75. Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. J Allergy Clin Immunol 2002 110: 484 8.
76. Nettis E, Dambra P, D'Oronzio L, Loria MP, Ferrannini A, Tursi A. Comparison of montelukast and fexofenadine for chronic idiopathic urticaria. Arch Dermatol 2001 137: 99 100.
77. Grattan CE, O'Donnell BF, Francis DM et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000 143: 365 72.
78. Baskan EB, Tunali S, Turker T, Saricaoglu H. Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria. J Dermatolog Treat 2004 15: 164 8.
79. Di Gioacchino M, Di Stefano F, Cavallucci E et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 2003 24: 285 90.
80. Kessel A, Bamberger E, Toubi E. Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study. J Am Acad Dermatol 2005 52: 145 8.
81. Cicardi M, Bergamaschini L, Zingale LC, Gioffre D, Agostoni A. Idiopathic nonhistaminergic angioedema. Am J Med 1999 106: 650 4.
82. Laurberg G. Tranexamic acid (Cyklokapron) in chronic urticaria: a double-blind study. Acta Derm Venereol 1977 57: 369 70.
83. Monroe EW, Cohen SH, Kalbfleisch J, Schulz CI. Combined H1 and H2 antihistamine therapy in chronic urticaria. Arch Dermatol 1981 117: 404 7.
84. Paul E, Bodeker RH. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients. Eur J Clin Pharmacol 1986 31: 277 80.
85. Bleehen SS, Thomas SE, Greaves MW et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: a multi-centre randomized double-blind study. Br J Dermatol 1987 117: 81 8.
86. Black AK, Greaves MW. Antihistamines in urticaria and angioedema. Clin Allergy Immunol 2002 17: 249 86.
87. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999 318: 593 6.
88. British Thoracic Society (BTS) British guideline on the management of asthma. Thorax 2003 58 (Suppl. 1): i1 94.
89. Bressler RB, Sowell K, Huston DP. Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial. J Allergy Clin Immunol 1989 83: 756 63.
90. Asherson RA, Buchanan N, Kenwright S, Fletcher CM, Hughes GR. The normocomplementemic urticarial vasculitis syndrome-report of a case and response to colchicine. Clin Exp Dermatol 1991 16: 424 7.
91. Engler RJ, Squire E, Benson P. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol 1995 74: 155 9.
92. Jaffer AM. Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol 1991 88: 964 5.
93. Eiser AR, Singh P, Shanies HM. Sustained dapsone-induced remission of hypocomplementemic urticarial vasculitis - a case report. Angiology 1997 48: 1019 22.
94. Gonzalez P, Soriano V, Caballero T, Niveiro E. Idiopatic angioedema treated with dapsone. Allergol Immunopathol (Madrid) 2005 33: 54 6.
95. Gach JE, Sabroe RA, Greaves MW, Black AK. Methotrexate-responsive chronic idiopathic urticaria: a report of two cases. Br J Dermatol 2001 145: 340 3.
96. Stack PS. Methotrexate for urticarial vasculitis. Ann Allergy 1994 72: 36 8.
97. Parsad D, Pandhi R, Juneja A. Stanozolol in chronic urticaria: a double blind, placebo controlled trial. J Dermatol 2001 28: 299 302.
98. Parslew R, Pryce D, Ashworth J, Friedmann PS. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy 2000 30: 1161 5.
99. Aversano M, Caiazzo P, Iorio G, Ponticiello L, Lagana B, Leccese F. Improvement of chronic idiopathic urticaria with L-thyroxin: a new TSH role in immune response? Allergy 2005 60: 489 93.
100. Gaig P, Garcia-Ortega P, Enrique E, Richart C. Successful treatment of chronic idiopathic urticaria associated with thyroid autoimmunity. J Invest Allergol Clin Immunol 2000 10: 342 5.
101. Reeves GE, Boyle MJ, Bonfield J, Dobson P, Loewenthal M. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 2004 34: 182 6.
102. Minciullo PL, Saija A, Bonanno D, Ferlazzo E, Gangemi S. Montelukast-induced generalized urticaria. Ann Pharmacother 2004 38: 999 1001.
103. O'Donnell BF, Barr RM, Black AK et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998 138: 101 6.
104. Grattan C, Powell S, Humphreys F. Management and diagnostic guidelines for urticaria and angio-oedema. Br J Dermatol 2001 144: 708 14.
105. Nettis E, Colanardi MC, Ferrannini A, Tursi A. Suspected tartrazine-induced acute urticaria/angioedema is only rarely reproducible by oral rechallenge. Clin Exp Allergy 2003 33: 1725 9.
106. Dean T. Deputy director to the David Hide Asthma and Allergy Research Centre, 2005, Personal Communication.
107. Volonakis M, Katsarou-Katsari A, Stratigos J. Etiologic factors in childhood chronic urticaria. Ann Allergy 1992 69: 61 5.
108. Levy Y, Segal N, Weintrob N, Danon YL. Chronic urticaria: association with thyroid autoimmunity. Arch Dis Child 2003 88: 517 9.
109. Zauli D, Grassi A, Granito A et al. Prevalence of silent coeliac disease in atopics. Dig Liver Dis 2000 32: 775 9.
110. Gabrielli M, Candelli M, Cremonini F et al. Idiopathic chronic urticaria and celiac disease. Dig Dis Sci 2005 50: 1702 4.
111. Caminiti L, Passalacqua G, Magazzu G et al. Chronic urticaria and associated coeliac disease in children: a case-control study. Pediatr Allergy Immunol 2005 16: 428 32.
112. Joint Task Force on Practice Parameters. The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol 2000 85: 521 44.
113. Greaves MW. Chronic urticaria in childhood. Allergy 2000 55: 309 20.
114. Heinonen OP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton, MA, USA: Littleton Publishing Sciences Group, 1977.
115. Aselton P, Jick H, Milunsky A, Hunter JR, Stergachis A. First-trimester drug use and congenital disorders. Obstet Gynecol 1985 65: 451 5.
116. Jick H, Holmes LB, Hunter JR, Madsen S, Stergachis A. First-trimester drug use and congenital disorders. JAMA 1981 246: 343 6.
117. Kallen B. Use of antihistamine drugs in early pregnancy and delivery outcome. J Matern Fetal Neonatal Med 2002 11: 146 52.
118. Diav-Citrin O, Shechtman S, Aharonovich A et al. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study. J Allergy Clin Immunol 2003 111: 1239 43.
119. Einarson A, Bailey B, Jung G, Spizzirri D, Baillie M, Koren G. Prospective controlled study of hydroxyzine and cetirizine in pregnancy. Ann Allergy Asthma Immunol 1997 78: 183 6.
120. Hilbert J, Radwanski E, Affrime MB et al. Excretion of loratadine in human breast milk. J Clin Pharmacol 1988 28: 234 9.
121. Briggs GB, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation, 6th Edn., Hagerstown, MD, USA: Lippincott Williams & Wilkins, 2001.